HCPLive Network

Regularly Breaking a Sweat May Lower Incident Stroke Risk

THURSDAY, July 18 (HealthDay News) -- Physical inactivity is associated with an increased risk of incident stroke, which is mediated via traditional risk factors, according to a study published online July 18 in Stroke.

Michelle N. McDonnell, PhD, from the University of South Australia in Adelaide, and colleagues compared the associations of self-reported physical activity (PA) with incident stroke among black and white participants in the Reasons for Geographic and Racial Differences in Stroke study. Analyses involved 27,348 participants aged 45 years or older without prior stroke, with follow-up every six months for stroke events. Moderate to vigorous intensity PA at baseline was classified by frequency as none (inactivity), one to three times per week, and four or more times per week.

During an average follow-up of 5.7 years, the researchers found that 33 percent of participants reported physical inactivity. Exercising at moderate to vigorous intensity (enough to break a sweat) correlated with a 20 percent reduced risk of incident stroke. The correlation was not affected by adjustment for demographic and socioeconomic factors, but was partially attenuated by adjustment for traditional stroke risk factors (diabetes, hypertension, body mass index, alcohol use, and smoking) (hazard ratio, 1.14; P = 0.17). PA frequency did not correlate significantly with the risk of stroke by sex groups, although a trend toward increased risk was observed for men reporting PA zero to three versus four or more times per week.

"Self-reported low PA frequency is associated with increased risk of incident stroke," the authors write. "Any effect of PA is likely to be mediated through reducing traditional risk factors."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Medical patients sometimes hear what we say skeptically, but Americans in general will believe any darn thing.
Bristol-Myers Squibb announced today the US Food and Drug Administration (FDA), had granted approval for Evotaz tablets in combination with other antiretroviral agents for an innovative treatment option for adults suffering from HIV-1 infection – delivering proven suppression through 48 weeks.
Researchers have found that menopause typically begins 2 to 4 years earlier in women with high levels of certain chemicals found in household items, personal care products, plastics, and the environment, compared to women with lower levels of the chemicals. The study was published online Jan. 28 in PLOS ONE.
More Reading